Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Neuronetics, Inc. Common Stock (STIM)

Surgical & Medical Instruments & Apparatus

https://www.neurostar.com

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

3222 PHOENIXVILLE PIKE
MALVERN, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/28/2018

Market Cap

34,839,825

Shares Outstanding

28,930,000

Weighted SO

28,933,132

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

BNR --.--%

DRIO --.--%

GTH --.--%

SERA --.--%

BDSX --.--%

FONR --.--%

ENZ --.--%

XGN --.--%

SHC --.--%

Beta

2.3190

Last Div

0.0000

Range

0.664-5.07

Chg

0.1847

Avg Vol

303700

Mkt Cap

34839825

Exch

NASDAQ

Country

US

Phone

610 640 4202

DCF Diff

4.4659

DCF

10.2659

Div Yield

0.0000

P/S

0.4835

EV Multiple

-2.1180

P/FV

1.7827

Div Yield %

0.0000

P/E

-1.0643

PEG

-0.2336

Payout

0.0000

Current Ratio

2.5807

Quick Ratio

2.3708

Cash Ratio

1.4574

DSO

98.7954

DIO

107.3622

Op Cycle

206.1576

DPO

71.7030

CCC

134.4546

Gross Margin

0.7102

Op Margin

-0.3978

Pretax Margin

-0.4506

Net Margin

-0.4506

Eff Tax Rate

0.1488

ROA

-0.3354

ROE

-1.0900

ROCE

-0.4243

NI/EBT

1.0000

EBT/EBIT

1.1329

EBIT/Rev

-0.3978

Debt Ratio

0.6261

D/E

3.1267

LT Debt/Cap

0.7042

Total Debt/Cap

0.7577

Int Coverage

-4.1962

CF/Debt

-0.4120

Equity Multi

4.9940

Rec Turnover

3.6945

Pay Turnover

5.0904

Inv Turnover

3.3997

FA Turnover

17.1257

Asset Turnover

0.7444

OCF/Share

-0.8311

FCF/Share

-0.9117

Cash/Share

1.4417

OCF/Sales

-0.3466

FCF/OCF

1.0970

CF Coverage

-0.4120

ST Coverage

-1.7262

CapEx Coverage

-10.3117

Div&CapEx Cov

-10.3117

P/BV

1.7827

P/B

1.7827

P/S

0.4835

P/E

-1.0643

P/FCF

-1.2717

P/OCF

-1.3838

P/CF

-1.3838

PEG

-0.2336

P/S

0.4835

EV Multiple

-2.1180

P/FV

1.7827

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 08, 08:30 Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results GlobeNewswire Inc. Dec 18, 08:49 Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory GlobeNewswire Inc. Dec 04, 08:56 NeuroStar TMS Receives Expanded Regulatory Approval in Japan GlobeNewswire Inc. Nov 09, 08:32 Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage GlobeNewswire Inc. Nov 07, 07:30 Neuronetics Reports Third Quarter 2023 Financial and Operating Results GlobeNewswire Inc. Nov 06, 16:30 Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Revenue Product Segmentation